the issue of pharmaceutical patents under the General Agreement on Tariffs and Trade [GATT] has been under review by this body for some time. Well respected individuals--from the Senate, from the Administration, and from the private sector--weighed in on both sides of the issue. Last December, I joined my Senate colleagues in voting to send this matter to the Judiciary Committee for hearings because I felt many questions remained unanswered about how certain patents were treated under the GATT. With no clear legislative history to follow, I believed--and still believe--it was important for Congress to carefully review the issue and get to the heart of the matter. I am pleased to note that my distinguished colleague from Utah, Senator Hatch, followed through on his commitment to hold hearings on pharmaceutical patents and the GATT, just as I knew he would. With his long history on addressing issues of concern to the generic drug industry, I had no question that he would do all he could to get to the bottom of this issue. The subsequent hearings were sorely needed so that the Senate could adequately consider the ramifications of the various courses of action proposed on this matter. Taking some time to adequately review an issue leads to better legislation and better results for Americans. This is a serious matter, and deserved serious and thoughtful review. Since those hearings concluded I have carefully reviewed the record on this complex issue.
Editor's note · Context
Discussing the review of pharmaceutical patents under GATT and the need for Senate hearings.
Share
More from Dirk Kempthorne
I add that the Senate conferees fought very hard to retain this important issue in the conference report, which was requested--and I will underscore this--by the Secretary of Defense and the Joint Chiefs of Staff. Mr. President, the bill…
As my distinguished colleague points out, the original provision was limited, focusing on increased efficiency and, wherever appropriate, information coordination. Congress did not intend to authorize a provision that created a sweeping…
I rise today to declare my concern over the dumping of barley into the American market by a European producer. I share the Idaho barley producers' outrage about the current unprecedented movement of heavily subsidized European Union feed…
I agree. They object to the scope of the proposed EFH program and are concerned that it will subject activities, including land development, agriculture, water supply, forestry, and mining, to the jurisdiction of the Fishery Management…





